Product Program year 2022 Source: CMS Open Payments

Spyglass

Device Biliary Devices

PDI 08714729764441

Open in the dashboard

General payments

$183,153

303 payments

Research payments

$175,859

28 payments

Through program year 2022, $183,153 in general payments and $175,859 in research payments were reported against Spyglass (Biliary Devices).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2022 General $24,294 28
2022 Research $175,859 28
2021 General $158,859 275

Breakdown

Who paid General payments · program years 2021–2022
  1. Boston Scientific Corporation $183,153 303 payments
Top recipients General payments · program year 2022
  1. Gulshan Parasher Internal Medicine · Albuquerque, NM $7,087 29% · 3 payments
  2. Rajesh Keswani Gastroenterology · Saint Louis, MO $4,640 19% · 3 payments
  3. Keck Hospital Of Usc Teaching hospital · CA $4,320 18% · 1 payment
  4. Horacio Asbun Surgical Oncology · Miami, FL $3,000 12% · 1 payment
  5. Kalpesh Patel Gastroenterology · Houston, TX $2,000 8% · 1 payment

The top 5 of 23 recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Gastroenterology Internal Medicine $9,210 46% · 8 practitioners
  2. Internal Medicine $7,087 35% · 1 practitioner
  3. Surgical Oncology Surgery $3,000 15% · 1 practitioner
  4. Vascular & Interventional Radiology Radiology $304 2% · 4 practitioners
  5. Diagnostic Radiology Radiology $279 1% · 4 practitioners

The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2022
  1. New Mexico $7,087 29% · 1 recipient
  2. Illinois $6,640 27% · 2 recipients
  3. California $4,320 18% · 1 recipient
  4. Florida $3,012 12% · 2 recipients
  5. Texas $2,425 10% · 2 recipients

The top 5 of 11 states; each share is of general payments naming this product in 2022 where a state was reported.

The top 25 states, free in the app

303 general · 28 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record